Fukuda Denshi Co Ltd
TSE:6960

Watchlist Manager
Fukuda Denshi Co Ltd Logo
Fukuda Denshi Co Ltd
TSE:6960
Watchlist
Price: 10 060 JPY 2.13%
Market Cap: ¥290B

P/S

2
Current
45%
More Expensive
vs 3-y average of 1.4

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
2
=
Market Cap
¥270.3B
/
Revenue
¥138.5B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
2
=
Market Cap
¥270.3B
/
Revenue
¥138.5B

Valuation Scenarios

Fukuda Denshi Co Ltd is trading above its 3-year average

If P/S returns to its 3-Year Average (1.4), the stock would be worth ¥6 918.69 (31% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-47%
Maximum Upside
No Upside Scenarios
Average Downside
31%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 2 ¥10 060
0%
3-Year Average 1.4 ¥6 918.69
-31%
5-Year Average 1.1 ¥5 352.79
-47%
Industry Average 2 ¥9 940.82
-1%
Country Average 1.1 ¥5 580.55
-45%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
¥270.3B
/
Jan 2026
¥138.5B
=
2
Current
¥270.3B
/
Mar 2026
¥139.5B
=
1.9
Forward
¥270.3B
/
Mar 2027
¥143.7B
=
1.9
Forward
¥270.3B
/
Mar 2028
¥148.5B
=
1.8
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close
Market Cap P/S P/E
JP
Fukuda Denshi Co Ltd
TSE:6960
274.7B JPY 2 15.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
161.2B USD 16 56.4
US
Abbott Laboratories
NYSE:ABT
158.6B USD 3.5 25.3
US
Stryker Corp
NYSE:SYK
120.5B USD 4.8 37.1
IE
Medtronic PLC
NYSE:MDT
101.9B USD 2.9 22.1
US
Boston Scientific Corp
NYSE:BSX
84.8B USD 4.1 23.8
US
Edwards Lifesciences Corp
NYSE:EW
47.2B USD 7.5 43
DE
Siemens Healthineers AG
XETRA:SHL
38.3B EUR 1.7 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.1B USD 10.3 41.7
US
Becton Dickinson and Co
NYSE:BDX
41.4B USD 1.9 23.5
US
Resmed Inc
NYSE:RMD
30.9B USD 5.7 20.8

Market Distribution

Higher than 72% of companies in Japan
Percentile
72nd
Based on 5 249 companies
72nd percentile
2
Low
0 — 0.7
Typical Range
0.7 — 1.9
High
1.9 —
Distribution Statistics
Japan
Min 0
30th Percentile 0.7
Median 1.1
70th Percentile 1.9
Max 12 107 466

Fukuda Denshi Co Ltd
Glance View

Market Cap
290B JPY
Industry
Health Care

Fukuda Denshi Co Ltd. is a stalwart in the medical technology arena, having carved out a niche as a leading provider of innovative medical devices and systems. Founded in the mid-20th century, the company has stayed true to its mission of enhancing global healthcare with cutting-edge solutions. Over the years, Fukuda Denshi has evolved its product range to encompass a wide array of essential medical equipment, including electrocardiographs, patient monitoring systems, and ultrasonic diagnosis devices. These products are instrumental in hospitals and clinics for accurate patient diagnostics and monitoring, crucial for effective medical decision-making and improved patient outcomes. The company's journey from a modest operation to a global player is a testament to its commitment to research and development, enabling it to produce technologically advanced and reliable products. Fukuda Denshi's revenue model is primarily driven by the sales of its medical devices and systems across various healthcare settings globally. The company continually invests in innovation, ensuring that its products maintain a competitive edge in terms of functionality and reliability. By forming strategic alliances and partnerships, Fukuda Denshi expands its market reach and supports its distribution channels effectively. Additionally, the company provides comprehensive after-sales services, including maintenance and training, ensuring that healthcare providers can optimize the use of its devices. This service component not only enhances customer satisfaction but also establishes long-term relationships, contributing to recurring revenue streams and sustained business growth. Through a business model synergizing product excellence and strategic market engagement, Fukuda Denshi has solidified its position in the healthcare industry, meeting the growing demands for quality medical technology worldwide.

Intrinsic Value
7 637.51 JPY
Overvaluation 24%
Intrinsic Value
Price ¥10 060
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett